BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34182015)

  • 1. Sensing technologies and experimental platforms for the characterization of advanced oral drug delivery systems.
    Okeyo PO; Rajendran ST; Zór K; Boisen A
    Adv Drug Deliv Rev; 2021 Sep; 176():113850. PubMed ID: 34182015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization.
    Stanković M; Frijlink HW; Hinrichs WL
    Drug Discov Today; 2015 Jul; 20(7):812-23. PubMed ID: 25660507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osmotically controlled drug delivery system with associated drugs.
    Gupta BP; Thakur N; Jain NP; Banweer J; Jain S
    J Pharm Pharm Sci; 2010; 13(4):571-88. PubMed ID: 21486532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supercritical fluid (SCF)-assisted fabrication of carrier-free drugs: An eco-friendly welcome to active pharmaceutical ingredients (APIs).
    Kankala RK; Xu PY; Chen BQ; Wang SB; Chen AZ
    Adv Drug Deliv Rev; 2021 Sep; 176():113846. PubMed ID: 34197896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-emulsifying Drug Delivery System Improve Oral Bioavailability: Role of Excipients and Physico-chemical Characterization.
    Zhu Y; Ye J; Zhang Q
    Pharm Nanotechnol; 2020; 8(4):290-301. PubMed ID: 32781978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced technologies for oral controlled release: cyclodextrins for oral controlled release.
    Salústio PJ; Pontes P; Conduto C; Sanches I; Carvalho C; Arrais J; Marques HM
    AAPS PharmSciTech; 2011 Dec; 12(4):1276-92. PubMed ID: 21948320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical solid dispersion technology: a strategy to improve dissolution of poorly water-soluble drugs.
    Kumar S; Gupta SK
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):111-21. PubMed ID: 23331062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Premix technologies for drug delivery: manufacturing, applications, and opportunities in regulatory filing.
    Ashokbhai MK; Sanjay LR; Sah SK; Roy S; Kaity S
    Drug Discov Today; 2024 Jun; 29(6):104011. PubMed ID: 38705511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to measure release from nanosized carriers?
    Nothnagel L; Wacker MG
    Eur J Pharm Sci; 2018 Jul; 120():199-211. PubMed ID: 29751101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered nanoparticulate drug delivery systems: the next frontier for oral administration?
    Diab R; Jaafar-Maalej C; Fessi H; Maincent P
    AAPS J; 2012 Dec; 14(4):688-702. PubMed ID: 22767270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melt extrusion: process to product.
    Repka MA; Shah S; Lu J; Maddineni S; Morott J; Patwardhan K; Mohammed NN
    Expert Opin Drug Deliv; 2012 Jan; 9(1):105-25. PubMed ID: 22145932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of polymeric colloidal nanogels in transdermal drug delivery.
    Mavuso S; Marimuthu T; Choonara YE; Kumar P; du Toit LC; Pillay V
    Curr Pharm Des; 2015; 21(20):2801-13. PubMed ID: 25925117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal drug delivery and 3D printing technologies: A focus on special patient populations.
    Karavasili C; Eleftheriadis GK; Gioumouxouzis C; Andriotis EG; Fatouros DG
    Adv Drug Deliv Rev; 2021 Sep; 176():113858. PubMed ID: 34237405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubilization of poorly water-soluble drugs using solid dispersions.
    Tran TT; Tran PH; Khanh TN; Van TV; Lee BJ
    Recent Pat Drug Deliv Formul; 2013 Aug; 7(2):122-33. PubMed ID: 23244679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
    Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
    Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioadhesive microspheres as a controlled drug delivery system.
    Vasir JK; Tambwekar K; Garg S
    Int J Pharm; 2003 Apr; 255(1-2):13-32. PubMed ID: 12672598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of solid lipid nanoparticles for sustained drug release.
    Attama AA; Umeyor CE
    Ther Deliv; 2015; 6(6):669-84. PubMed ID: 26149784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical Additive Manufacturing: a Novel Tool for Complex and Personalized Drug Delivery Systems.
    Zhang J; Vo AQ; Feng X; Bandari S; Repka MA
    AAPS PharmSciTech; 2018 Nov; 19(8):3388-3402. PubMed ID: 29943281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionally engineered nanosized particles in pharmaceutics: improved oral delivery of poorly water-soluble drugs.
    Ozeki T; Tagami T
    Curr Pharm Des; 2013; 19(35):6259-69. PubMed ID: 23470003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.